| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |